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ABSTRACT 
Background: Laryngopharyngeal Reflux (LPR) describes as retrograde reflux from 
gaster into the laryngopharynx because of the premature relaxation upper esophageal 
sphincter. The management of LPR patients includes lifestyle and dietary 
arrangements, medical therapy and surgical management. Nigella sativa (NS) / black 
cumin has anti-inflammatory, anti-oxidant and gastroprotective effects that are 
expected to provide clinical improvement in LPR patients. 
Objective: The purpose of this study was to determine the effectiveness of NS on 
the clinical improvement of LPR patients 
Methods: This research is an intervention study using pre and post-test design 
methods of 34 LPR patients in Dr. Kariadi, hospital and 2 affiliated hospitals from 
November 2019 - March 2020.  
Results:  24 patients with complete data while 10 patients were unable to evaluate 
RFS because of a pandemic. The treatment group (15 patients) were given 
omeprazole 20 mg / 12 hours plus NS 1000 mg / 12 hours orally and control group 
(9 patients) were given omeprazole 20 mg / 12 hours orally and placebo. Data were 
tested by Shapiro Wilk test, followed by the appropriate parametric test, and Fisher's 
exact test. There were no differences in clinical improvement in LPR based on RSI 
and RFS values between groups given additional NS and groups without NS, p 0.105. 
Conclusion: there were no significant differences in clinical improvement between 
groups given additional NS and groups without NS. 
 






Laryngopharyngeal Reflux (LPR) decribes as 
retrograde reflux from gaster into the 
laryngopharynx because of the premature 
relaxation upper esophageal sphincter. The 
premature relaxation of upper esophageal sphincter 
causes refluxate to rise into the laryngopharyngeal 
area.1 The result is a pathological process that is 
chronic inflammation in the laryngopharyngeal 
area. Patients who come to the ENT clinic, about 4-
10% have LPR complaints.2 Nine questions in the 
Reflux Symptoms Index (RSI) are used to measure 
complaints experienced by patients. Reflux Finding 
Score (RFS) which consist of eight items found 
from the laryngopharyngeal clinical examinations 
that associated with LPR patient complaints. LPR is 
diagnosed by RSI > 13 and RFS > 7.1  
Nigella sativa (black cumin) is a species of the 
genus Nigella which has 25 species of plants that 
belong to the Ranunculaceae family. The liquid 
extract of Nigella sativa has been researched to have 
immunomodulatory effect, anti-inflammatory, 
analgesic, antipyretic, anti-secretory gastric 
activity, anti-ulcer activity in the gastrointestinal 
tract, hepatoprotective, antimicrobial, and anti-
cancer.3 
The administration of 2 grams Nigella sativa a 
day can have an eradicating effect on Helicobacter 
pylori.4 Several studies mention Nigella sativa in 
liquid form provides a protective effect on the 
gastric mucosa. The effectiveness of Nigella sativa 
in the gastrointestinal tract shows that Nigella sativa 
increases mucin, reduces acidity and glutathione 
levels and decreases histamine release in the 
gastric.5
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Gastroprotective effects of Nigella sativa occur 
due to proton pump inhibition, gastric acid secretion 
and neutrophil infiltration as well as increased mucin 
secretion.3 Nigella sativa also has effectiveness as an 
anti-inflammatory and anti-oxidant by inhibiting pro-
inflammatory mediators.6 The effect of Nigella sativa 
as anti-inflammatory, anti-oxidant and 
gastroprotective is what is expected to provide 
clinical improvement in LPR patients.3, 6 Research on 
the effectiveness of Nigella sativa in LPR patients has 
never been done.  
2. Methods  
The study involved 34 patients, divided into 17 
patients as a control group and 17 patients as a 
treatment group. Qualified samples are LPR patients 
with RSI scores > 13 and RFS score > 7 at Merpati 
ENT-HNS clinic and Central Surgery Installation of 
Dr. RSUP. Kariadi Semarang, ENT-HNS clinic Dr. 
Soetrasno Rembang Hospital and Dr. Soeselo Slawi 
in November 2019 - March 2020. The treatment 
group was LPR patients who received standard LPR 
therapy (Omeprazole 20 mg every 12 hours) added 
with 1 gram liquid Nigella sativa wrapped in 
capsules, gived every 12 hours. The control group 
was LPR patients who received standard therapy and 
placebo. The laryngopharyngeal examination were 
carried out with the Olympus BFP 160 flexible 
laryngoscopy and the scope of Olympus Exera 2 and 
Ambu Scope. 8 patients in the control group and 2 
patients in the treatment group were unable to do an 
RFS examination at the end of the study because of a 
pandemic.  This study used a Randomized Controlled 
Trial test with a Pre Test and Post Test Control Trial 
Group design. Statistical data analysis uses the SPSS 
(Statistical Product and Service Solution) program. 
Data were tested by Shapiro Wilk test, followed by 
the appropriate parametric test, Fisher's exact test.  
Ethical clearance from the Medical Research 
Ethics Commission FK UNDIP / RSUP Dr. Kariadi 
Semarang on 5 November 2019 with number 395 / 
EC / KEPK-RSDK / 2019. Permission from RSUP 
Dr. Kariadi on 28 November 2019 number DP0.2.01 
/ I.II / 6539/2019. A permit to carry out research from 
the RSUD Dr. Soetrasno Rembang on February 9, 
2020. Director's license Dr. Soesilo Slawi with 
number 005/27/3994/2020 on 7 February 2020 based 
on recommendations from the Research Ethics 
Committee of RSUD Dr. Soeselo Slawi on 5 
February 2020.  
 
3. Results 
Table 1 explains the  the characteristics Dof the 
subjects including age, sex, BMI, and diet during the 
study
 
Table 1. The characteristic of the subjects 
Variabels 
Group 
p¥ Treatment (n=15) Control (n=9) 
n % N % 
Age      
 18 – 40 years 5 33,3 2 22,2 0,669 
 41 – 60 years 10 66,7 7 77,8  
Sex      
 Male 1 6,7 2 22,2 0,533 
 Female 14 93,3 7 77,8  
BMI      
 Underweight 0 0 1 11,1 0,274 
 Normal 9 60 5 55,6  
 Overweight 3 20 3 33,3  
 Obesity 3 20 0 0  
Diet      
 Coffee  3 20 2 22,2 1,000 
 Tea 13 86,7 8 88,9 1,000 
 Spicy foods 10 66,7 5 55,6 0,678 
       * Significant (p < 0,05); ¥ Chi square 
 
Most subjects with age ranges 41-60 years in 
both groups. More female sex in the treatment group 
(14 patients) and control (7 patients). Both research 
groups had normal BMI. Tea is a type of beverage 
that is often consumed by subjects followed by spicy 
foods in both groups. None of the subjects consumed 
soft drinks, alcohol and smoking in both groups. 
There were no significant differences in age, sex, 
BMI and diet in the two groups. 
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   Figure 1. Mean of RSI in the control and treatment groups  
 
Figure 1 shows the RSI in the control and 
treatment groups before, day 14th evaluation and 
after the study. There were significant differences in 
the RSI in each control group and treatment before 
and after the study with p <0.05. The decrease in RSI 
was seen in the control and treatment groups from 
before to after the study, which means that there was 




     Figure 2. Mean of RFS in control and treatment groups 
 
Figure 2 shows the significant differences in RFS 
in each control group and the treatment before and 
after treatment with p <0.05. The decrease in RFS in 
the control and treatment groups from before the 
study to after the completion of the study meant that 
there was an improvement when evaluating with 
flexible laryngoscopy. 
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Reflux Finding Score Treatment
Control
∆ -10,40 ± 6,09 
p <0,001¶* 
p 0,007†* 
∆ -10,78 ± 6,14 
∆ -3,89 ± 2,57 
∆ -3,20 ± 2,68 
p 0,002†*  
p 0,002¶* 
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Table 2 shows no significant differences in the 
decrease in RSI and RFS between groups with p> 
0.05. But there was clinical improvement in both 
groups (decrease in RSI> 3 and RFS> 2). 
 






 Yes 6 (40%) 7 (77,8%) 0,105£ 
 No 9 (60%) 2 (22,2%)  
* Significant (p < 0,05); £ Fisher’s exact test 
 
Table 3 shows the clinical improvement assessed 
based on a decrease in the two values, the RSI and 
RFS values between groups which were not 
significantly different. 
4. Discussion 
The study included 24 LPR patients with the 
lowest age of 19 years and the highest of 60 years. 
Most age groups are 41 - 60 years. These results are 
the same as the results of a study conducted by 
Lechien et al in LPR patients in 3 hospitals in 
Germany with the most age group 41-60 years.7 
Research conducted on 229 patients given PPI, found 
that increasing age can cause accumulation of 
stomach acid but it can also occur damage from 
intrinsic defense, gastric emptying mechanism for 
longer, changes in resistance of the mucosa. This is 
why the RSI is greater in patients with older.8 The 
results showed more LPR patients in the female sex 
(21 patients) compared to men (3 patients). Recent 
research suggests that women have low levels of 
Carbonic Anhydrase isoenzyme III (CA-III) so that 
LPR complaints in women appear first when 
compared to men. CA-III is an important defense 
mechanism by increasing the buffering capacity of 
inflammation.9 The highest BMI in the study subjects 
was in the normal BMI category (9 subjects in the 
treatment group and 5 subjects in the control group). 
The relationship between LPR and obesity cannot be 
explained with certainty. Eating arrangements, 
weight loss (BMI <25 kg / m2) will reduce intra-
abdominal pressure, gastric distension, and relaxation 
of the lower esophageal sphincter thereby reducing 
reflux.1 The study by Lechien involving 65 LPR 
patients in Belgium showed significant 
improvements in the group that maintained their diet 
and lifestyle modification by not consuming foods 
such as soft drinks, caffeine, alcohol, fatty foods and 
smoking.5       
This study showed a decrease in the mean RSI 
before, day 14 and after the study in both groups 
(Figure 1). The mean of RSI had decrease 
significantly at the end of the study when compared 
with the mean of RSI before the study. It means an 
improvement in complaints from research subjects. 
This can occur because each group received standard 
therapy and then added placebo in the control group 
and Nigella sativa in the treatment group. Nigella 
sativa has never been studied in patients with LPR 
before. Research conducted on 88 dyspepsia patients 
showed improvement in reflux complaints, reduction 
in the number of Helicobacter pylori after being given 
Nigella.4 Animal studies given Nigella sativa showed 
decreased gastric acid volume, pepsin concentration, 
gastric acidity.10  This study shows that the mean RFS 
before and after the study in the control group was 
higher when compared to the treatment group (Figure 
2). The mean of RFS also had decrease significantly 
at the end of the study. Research on the effects of 
Nigella sativa on the laryngeal mucosa has never 
been done before. Research conducted shows the 
proton pump inhibition process, decreased gastric 
secretion, increased gastric pH, improved gastric 
mucosa and increased mucus secretion that protects 
the epithelial layer so that it is expected to improve 
the laryngeal mucosal picture on endoscopic 
examination and reduce complaints in LPR patients.3, 
11, 12 The effect of omeprazole as a standard therapy 
that works to reduce the activation of gastric acid 
secretion, maintain intragastric pH>4 so that there is 
an improvement during endoscopic examination.1, 13, 
14 Difference between RSI and RFS between groups 
was no significant. But there was a clinical 
improvement in both groups marked by a decrease in 
RSI > 3 and RFS > 2, although it was not statistically 
significant (Table 3). 
5. Conclusion  
There were no significant differences in clinical 
improvement between groups given additional NS 
and groups without NS. 
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